Nasiri Naser, Abedi Leili, Hajebi Ahmad, Noroozi Alireza, Khalili Malahat, Chegeni Maryam, Nili Sairan, Taheri-Soodejani Moslem, Noroozi Mehdi, Shahesmaeili Armita, Sharifi Hamid
Department of Public Health, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran.
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Addict Health. 2019 Jul;11(3):173-182. doi: 10.22122/ahj.v11i3.240.
Estimating the population who use drugs is essential for planning, monitoring, and evaluation of substance use prevention and treatment. This study aims to estimate the population who misuse tramadol in urban population in Iran.
We used the wisdom of the experts (WOTE) and network scale-up (NSU) methods to calculate the population of tramadol misusers in 10 provincial capitals of Iran, in 2016. The WOTE was conducted among pharmacists in drugstores and the personnel of traditional medicinal herbs stores. They guessed the best estimation of tramadol misusers population in their cities. The NSU method was conducted among the general population and participants were questioned about ever and daily, non-medical use of tramadol during last 12 months in their network. The median of the methods was used to calculate the proportion of the adult population (15-49 years old).
The population size of tramadol misusers in studied cities was 83300 [95% uncertainty limits (UL): 47960-256220]. This corresponded to 6.6 per 1000 (95% UL: 3.88-20.30) of the 15-49-year-old population. The projected number of tramadol misusers for all 31 provincial capitals was 118290 (95% UL: 68100-363130840) and 212440 (95% UL: 122310-653410) for all urban areas. NSU also estimated the number of people who misuse tramadol on daily basis. These numbers were 52000 (95% UL: 19940-176570) for studied cities, 73840 (95% UL: 28320-250740) for all 31 provincial capital cities, and 132610 (95% UL: 50860-450310) for all urban areas in Iran.
This study presents information on high prevalence of tramadol misuse in urban population. We need national control measures and demand reduction programs to control tramadol misuse.
估计吸毒人群对于物质使用预防和治疗的规划、监测及评估至关重要。本研究旨在估计伊朗城市人口中滥用曲马多的人群数量。
我们采用专家智慧法(WOTE)和网络扩大法(NSU)来计算2016年伊朗10个省会城市中曲马多滥用者的数量。WOTE方法应用于药店药剂师和传统草药商店工作人员,他们猜测所在城市曲马多滥用者人群的最佳估计数。NSU方法应用于普通人群,参与者被询问在过去12个月里其社交网络中是否曾有以及每日非医疗使用曲马多的情况。采用两种方法的中位数来计算成年人口(15至49岁)的比例。
所研究城市中曲马多滥用者的人口规模为83300[95%不确定区间(UL):47960 - 256220]。这相当于15至49岁人口的千分之6.6(95% UL:3.88 - 20.30)。所有31个省会城市曲马多滥用者的预计数量为118290(95% UL:68100 - 363130840),所有城市地区为212440(95% UL:122310 - 653,410)。NSU还估计了每日滥用曲马多的人数。所研究城市的这些数字为52000(95% UL:19940 - 176570),所有31个省会城市为73840(95% UL:28320 - 250740),伊朗所有城市地区为132610(95% UL:50860 - 450310)。
本研究提供了城市人口中曲马多滥用高流行率的信息。我们需要国家控制措施和减少需求计划来控制曲马多滥用。